Related Experiment Video

Updated: May 3, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.1K

NLRC5 mediates cytokine secretion in RAW264.7 macrophages and modulated by the JAK2/STAT3 pathway

Lin Li1, Tao Xu, Cheng Huang

  • 1School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei, 230032, China.

Inflammation
|January 22, 2014
PubMed

Insights

Nucleotide-binding domain leucine-rich repeat protein 5 (NLRC5) negatively regulates interleukin-6 and tumor necrosis factor-α secretion. Inhibition of the JAK2/STAT3 pathway decreases NLRC5 expression, revealing a novel regulatory mechanism in innate immunity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cellular Biology

Background:

  • Nucleotide-binding domain leucine-rich repeat proteins (NLRs) are crucial innate immune receptors.
  • NLRC5, the largest NLR family member, is a key regulator of immune responses.
  • Understanding NLRC5's role in cytokine regulation and its upstream signaling is vital.

Purpose of the Study:

  • To investigate the role of NLRC5 in regulating cytokine secretion (IL-6 and TNF-α).
  • To explore the involvement of the JAK2/STAT3 signaling pathway in lipopolysaccharide-induced NLRC5 expression.
  • To elucidate the regulatory relationship between NLRC5 and the JAK2/STAT3 pathway.

Main Methods:

  • Overexpression and siRNA-mediated knockdown of NLRC5 in RAW264.7 cells.
  • Measurement of IL-6 and TNF-α secretion levels.
  • Pharmacological inhibition (AG490) and siRNA knockdown of JAK2/STAT3 signaling.
  • Analysis of NLRC5, p-JAK2, and p-STAT3 expression levels.

Main Results:

  • NLRC5 overexpression downregulated IL-6 and TNF-α secretion.
  • NLRC5 knockdown enhanced IL-6 and TNF-α secretion, indicating a negative regulatory role.
  • Inhibition of JAK2/STAT3 signaling by AG490 or JAK2 siRNA reduced NLRC5 expression.
  • JAK2/STAT3 pathway inhibition also decreased the expression of phosphorylated JAK2 and STAT3.

Conclusions:

  • NLRC5 acts as a negative regulator of IL-6 and TNF-α secretion.
  • The JAK2/STAT3 signaling pathway positively regulates NLRC5 expression.
  • This study reveals a novel mechanism where JAK2/STAT3 inhibition leads to decreased NLRC5 expression.

More Related Videos

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

7.2K
A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces07:55

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces

Published on: January 7, 2020

6.8K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K